한글목차

세계 스마트 붕대 시장 규모는 2024년에 8억 2,378만 달러에 달했습니다. 2033년에는 32억 2,730만 달러에 달할 것으로 예상되며, 예측 기간인 2025년부터 2033년까지 14.6%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.

스마트 붕대는 센서, 약물 전달 시스템, 실시간 모니터링 기능을 갖춘 첨단 상처 관리용 붕대입니다. 수분 수준, pH 균형, 세균 감염 등 상처 상태를 추적하여 의료 전문가에게 귀중한 데이터를 제공합니다. 일부 스마트 붕대는 상처 부위에 직접 약물을 투여하여 조기 회복을 촉진하고 드레싱 교체 횟수를 줄일 수 있습니다.

이러한 붕대는 만성 상처, 화상, 수술 후 치료에 특히 효과적이며, 합병증을 최소화하고 환자 결과를 개선하는 데 도움이 될 수 있습니다. 그래핀과 하이드로겔과 같은 소재의 발전으로 스마트 붕대는 더욱 유연하고 효율성이 높아지고 있습니다.

세계 스마트 붕대 시장은 만성 상처 증가, 특히 당뇨병, 비만, 순환 장애를 앓고 있는 수백만 명의 사람들이 앓고 있는 만성 상처 증가에 의해 주도되고 있습니다. 기존의 상처 치료 방법으로는 이러한 상태를 관리하는 데 어려움이 있어 스마트 붕대와 같은 첨단 솔루션에 대한 수요가 증가하고 있습니다. 스마트 드레싱은 실시간 모니터링, 수분 조절, 약물 전달 기능을 제공하여 상처 치유 결과를 개선할 수 있습니다. 만성 상처의 발생률이 증가함에 따라 스마트 붕대 채택이 확대되어 환자 치료를 개선하고 의료 비용을 절감할 수 있을 것으로 기대됩니다.

예를 들어, NCBI의 조사에 따르면, 새로운 만성 상처 환자는 연간 866명, 연평균 54명입니다. 만성 궤양의 발병률은 인구 1.2/1,000명당 1.2명이었고, 유병률은 3.3/1,000명당 1.3명이었습니다. 환자의 대부분은 남성(57.2%)이었고, 평균 연령은 41.7세±20.6세였습니다. 외상 후가 주요 원인이며, 연령은 병인과 양의 상관관계가 있습니다. 겸상적혈구 및 정맥성 상처는 주로 하지에서 나타났으며, 연령이 높아질수록 만성 상처의 발생과 상관관계가 있었습니다.

세계 스마트 붕대 시장은 FDA와 EMA의 엄격한 규제 승인 절차로 인해 어려움을 겪고 있습니다. 이러한 복잡한 프로세스는 제품 출시 지연, 시장 진입 시간 및 투자 증가, 각기 다른 지역의 제조업체들이 세계 상용화를 어렵게 만들어 시장 성장을 제한할 수 있습니다.

세계의 스마트 붕대(Smart Bandage) 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별/기술별/용도별/유통 채널별/지역별 동향, 경쟁 구도, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 서론과 범위

제2장 주요 인사이트와 중요 포인트

제3장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석

제4장 전략적 인사이트와 업계 전망

• 시장 리더와 선구자
• CXO의 견해
• 최신 개발과 Break through
• 사례 연구/진행중인 조사
• 규제와 상환 상황
• Porter의 Five Forces 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 요구와 갭
• 시장 진입 및 확장을 위한 추천 전략
• 시나리오 분석 베스트 케이스, 베이스 케이스, 워스트 케이스 예측
• 가격 분석과 가격 동향
• 주요 업계 리더

제5장 스마트 붕대 시장, 제품 유형별

• 그래핀 붕대
• 합성 섬유 붕대

제6장 스마트 붕대 시장, 기술별

• 무선 센서
• 플렉서블 전자

제7장 스마트 붕대 시장, 용도별

• 화상에 의한 만성 피부 손상
• 당뇨병에 의한 만성 피부 창상
• 기타 원인에 의한 만성 피부 창상

제8장 스마트 붕대 시장, 유통 채널별

• 소매 약국
• 병원 약국
• 기타

제9장 스마트 붕대 시장, 지역별 시장 분석과 성장 기회

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 라틴아메리카
  • 멕시코
  • 브라질
  • 아르헨티나
  • 기타
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타
• 중동 및 아프리카

제10장 경쟁 구도와 시장 포지셔닝

제11장 기업 개요

• Grapheal
• 3M Company
• The Wound Pros, Inc
• Baxter International Inc
• Coloplast A/S
• SURVIVAL

제12장 가정과 조사 방법

제13장 부록

영문목차

The global smart bandages market reached US$ 823.78 million in 2024 and is expected to reach US$ 3227.30 million by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smart bandages are advanced wound care dressings with sensors, drug delivery systems, and real-time monitoring capabilities. They track wound conditions like moisture levels, pH balance, and bacterial infections, providing valuable data to healthcare professionals. Some smart bandages can deliver medications directly to the wound site, promoting faster recovery and reducing dressing changes.

These dressings are particularly beneficial for chronic wounds, burns, and post-surgical care, minimizing complications and improving patient outcomes. With advancements in materials like graphene and hydrogel, smart bandages are becoming more flexible and efficient.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Wounds

The global smart bandages market is driven by the rise in chronic wounds, particularly those affecting millions of people with diabetes, obesity, and circulatory disorders. Traditional wound care methods struggle to manage these conditions, leading to a demand for advanced solutions like smart bandages. These dressings offer real-time monitoring, moisture regulation, and drug delivery capabilities, improving wound healing outcomes. As chronic wound incidence increases, smart bandage adoption is expected to grow, enhancing patient care and reducing healthcare costs.

For instance, according to an NCBI study, 866 patients with new chronic wounds were seen annually, with an average of 54 cases per year. Chronic ulcers develop at a rate of 1.2/1000 population, with a prevalence of 3.3/1000. Most patients were males (57.2%), with a mean age of 41.7 years +- 20.6. Post-traumatic wounds were the leading cause, with age positively correlated with aetiology. Sickle cell and venous wounds were predominantly on the legs, with an increasing age correlated with chronic wound occurrence.

Regulatory Challenges

The global smart bandage market faces challenges due to the stringent regulatory approval process set by the FDA and EMA, which requires medical devices to meet strict safety and efficacy standards. This complex process can cause delays in product launches, increase market entry time and investment, and make global commercialization challenging for manufacturers across different regions, limiting market growth.

Segment Analysis

The global smart bandages market is segmented based on product type, technology, application, distribution channel, and region.

Product Type:

The graphene-based bandages from the application segment are expected to dominate the smart bandages market with the highest market share

Graphene-based bandages are transforming the global smart bandages market by offering superior wound healing capabilities. Their exceptional electrical conductivity allows real-time wound monitoring, enabling early detection of infections. Graphene's high mechanical strength and flexibility ensure durability and patient comfort. Its natural antimicrobial properties reduce infection risk, making it beneficial for chronic wounds, burns, and diabetic ulcers. These bandages can also be integrated with drug delivery systems for controlled medication release. As demand for tech-enabled wound care solutions increases, graphene-based bandages are expected to drive significant advancements.

Geographical Analysis

North America is expected to hold a significant position in the Smart Bandages market with the highest market share

The North American smart bandages market is fueled by chronic wounds, such as diabetic ulcers and pressure sores, due to the aging population and diabetes cases. The region's strong healthcare infrastructure and reimbursement policies support advanced wound care solutions. Technological advancements, such as sensors and real-time monitoring, enhance the effectiveness of smart bandages. Leading medical device companies and substantial research investments fuel market growth. Growing awareness among healthcare professionals and patients about smart bandage benefits and increasing home healthcare adoption contribute to market expansion.

For instance, in June 2024, Chronic wounds, including diabetic ulcers and pressure injuries, have a poorer five-year survival rate than other serious diseases and cost an estimated $28 billion annually in the U.S. Treating wounds is expensive, with researchers from the Keck School of Medicine of USC and the California Institute of Technology developing advanced technologies to revolutionize wound care. These technologies include smart bandages that automatically respond to changing wound conditions, providing continuous data on healing and potential complications and enabling real-time delivery of medications or treatments.

Competitive Landscape

The major global players in the smart bandages market include Grapheal, 3M Company, The Wound Pros, Inc, Baxter International Inc, Coloplast A/S, SURVIVAL and among others.

Key Developments

• In June 2024, the Keck School of Medicine of USC and the California Institute of Technology developed advanced technologies, including smart bandages, to revolutionize wound care by automatically sensing and responding to changing conditions, providing continuous data on healing and potential complications, and potentially delivering drugs or treatments in real time.
• In May 2024, Researchers from the University of Southampton are developing smart bandages that enable remote monitoring and use LED lights to sterilize wounds as they heal, using ultraviolet-C light for treatment.

Why Purchase the Report?

• Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart bandages market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Product Type
• 2.4. Snippet by Technology
• 2.5. Snippet by Application
• 2.6. Snippet by Distribution Channel
• 2.7. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Prevalence of Chronic Wounds
    • 3.1.1.2. Advancements in Wearable Technologies
  • 3.1.2. Restraints
    • 3.1.2.1. Regulatory Challenges
    • 3.1.2.2. Technical Limitations
  • 3.1.3. Opportunity
    • 3.1.3.1. Emerging Markets Expansion
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East & Africa
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. Smart Bandages Market, By Product Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 5.1.2. Market Attractiveness Index, By Product Type
• 5.2. Graphene-Based Bandages*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Synthetic Fiber Bandages

6. Smart Bandages Market, By Technology

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 6.1.2. Market Attractiveness Index, By Technology
• 6.2. Wireless Sensors*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Flexible Electronic

7. Smart Bandages Market, By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Chronic Skin Wounds from Burns*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Chronic Skin Wounds from Diabetes
• 7.4. Chronic Skin Wounds from Other Causes

8. Smart Bandages Market, By Distribution Channel

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 8.1.2. Market Attractiveness Index, By Distribution Channel
• 8.2. Retail Pharmacies*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Hospital Pharmacies
• 8.4. Others

9. Smart Bandages Market, By Regional Market Analysis and Growth Opportunities

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.7.1. U.S.
    • 9.2.7.2. Canada
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.7.1. Germany
    • 9.3.7.2. U.K.
    • 9.3.7.3. France
    • 9.3.7.4. Spain
    • 9.3.7.5. Italy
    • 9.3.7.6. Rest of Europe
• 9.4. Latin America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.7.1. Mexico
    • 9.4.7.2. Brazil
    • 9.4.7.3. Argentina
    • 9.4.7.4. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.7.1. China
    • 9.5.7.2. India
    • 9.5.7.3. Japan
    • 9.5.7.4. South Korea
    • 9.5.7.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape and Market Positioning

• 10.1. Competitive Overview and Key Market Players
• 10.2. Market Share Analysis and Positioning Matrix
• 10.3. Strategic Partnerships, Mergers & Acquisitions
• 10.4. Key Developments in Product Portfolios and Innovations
• 10.5. Company Benchmarking

11. Company Profiles

• 11.1. Grapheal*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals, etc.
  • 11.1.5. SWOT Analysis
• 11.2. 3M Company
• 11.3. The Wound Pros, Inc
• 11.4. Baxter International Inc
• 11.5. Coloplast A/S
• 11.6. SURVIVAL

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

• 12.1. Data Collection Methods
• 12.2. Data Triangulation
• 12.3. Forecasting Techniques
• 12.4. Data Verification and Validation

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us